Scholars Central

Conference abstractPublished 17 Sep 2018

GanplexTM and Kimera-TestTM: Biotechnological screening tools designed identify human cancer-related virus and SNPs in non-invasive samples.

Authors: G Aguirre, Meda-Monzón E

Hakken Enterprise S.A. de C.V., Mexico; Hakken Enterprise S.A. de C.V., México

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Most efforts of allopathic medicine are directed to treat diseases. This path has proved to be costly when chronic diseases, such as cancer and its associated viral co-morbidities, need to be treated and monitored in the long term. Hence, the development of prevention-oriented medicine may reduce the magnitude of the financial burden associated with practicing remedy-based medicine. GanplexTM and Kimera-TestTM, the prime products of Hakken Enterprise, were then conceived to identify individuals with high genetic risk of developing cancer before the disease becomes symptomatic. GanplexTM and Kimera-TestTM take advantage of DNA extracted from saliva and urine samples to identify cancer-related viruses and SNPs through multiplex assays in a single reaction. At the current stage of development, both assays identify cancer-related SNPs and the viral sequences with a sensitivity, specificity, and confidence higher than those reported for Sanger’s sequencing. Both assays require small DNA quantities to begin with and no purification of PCR products prior hybridization. This shortens to approximately 7 hours the time to provide a result. Hence, GanplexTM and Kimera-TestTM are biotechnological tools that provide the genetic information needed to identify individuals under risk of developing cancer, a circumstance that would help in personalizing cancer preventing protocols and introducing precision medicine into everyday’s life. This work was financed by CONACyT (Grant No. 250884, 230066).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectBiochemistry & Biotechnology
  • SubjectInfectious Diseases
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “G Aguirre”
  • BylineArticles whose byline prints “Meda-Monzón E”